What is the Impact Factor of Diabetes Metabolic Syndrome and Obesity-Targets and Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Diabetes Metabolic Syndrome and Obesity-Targets and Therapy is 3.50, ranking in quartile Q2 of Web of Science (SCIE).

Is Diabetes Metabolic Syndrome and Obesity-Targets and Therapy indexed in Web of Science or Scopus?

Yes, Diabetes Metabolic Syndrome and Obesity-Targets and Therapy is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.890 (Q2) and an H-index of 80.

Who publishes Diabetes Metabolic Syndrome and Obesity-Targets and Therapy and what is the Article Processing Charge (APC)?

Diabetes Metabolic Syndrome and Obesity-Targets and Therapy is published by Dove Medical Press Ltd.. The estimated Article Processing Charge (APC) is approximately $3,208 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Diabetes Metabolic Syndrome and Obesity-Targets and Therapy?

The official ISO-4 abbreviation of Diabetes Metabolic Syndrome and Obesity-Targets and Therapy is "DIABET METAB SYND OB". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #5,876Hybrid

Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

Abbreviation (ISO):DIABET METAB SYND OB

•

Identifier (ISSN):1178-7007(Print)

•

Publisher:Dove Medical Press Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.5↑ +0.5

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Diabetes Metabolic Syndrome and Obesity-Targets and Therapy

WoS Q2

Annual Impact Factor Metric

Current (2026):3.5

Scopus SJR & RankScopus Q2

0.89

#5,876

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

80 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate3.6%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

439articles/year

99.63% Gold OA•89.97% Original Research

Aims & Scope

An international, peer-reviewed, open access, online journal. The journal is committed to the rapid publication of the latest laboratory and clinical findings in the fields of diabetes, metabolic syndrome and obesity research. Original research, review, case reports, hypothesis formation, expert opinion and commentaries are all considered for publication.

Topics Covered (Recognized by AI)

Medicine93.5%Biology93.2%Internal medicine90.5%Endocrinology90.4%Diabetes mellitus75.6%Pathology70.5%Chemistry48.3%Biochemistry45.8%Obesity41.6%Biotechnology35.4%Insulin35%Type 2 diabetes33.7%Genetics33.4%Mathematics32.8%Statistics29.9%Body mass index23.9%Sociology22%Psychology21.5%Surgery20.8%

Primary Research Areas

Pharmacology Toxicology and Pharmaceutics

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

ENDOCRINOLOGY & METABOLISM

Rank87/198

IndexSCIE

JCISCIE2026

ENDOCRINOLOGY & METABOLISM

Rank92/198

IndexSCIE

Category	Index	Rank	Quartile
ENDOCRINOLOGY & METABOLISM	JCRSCIE	87/198	Q2
ENDOCRINOLOGY & METABOLISM	JCISCIE	92/198	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.5

Articles / Year226

Total Citations65

2025

IF3

Articles / Year389

Total Citations1,059

2024

IF2.8

Articles / Year426

Total Citations2,699

2023

IF3.3

Articles / Year373

Total Citations4,081

2022

IF3.249

Articles / Year350

Total Citations4,978

Year	Impact Factor	Articles / Year	Total Citations
2026	3.5	226	65
2025	3	389	1,059
2024	2.8	426	2,699
2023	3.3	373	4,081
2022	3.249	350	4,978
2021	3.168	449	8,236
2020	2.842	489	12,452
2019	3.319	260	8,584
2018	2.961	98	3,225
2017	—	52	2,759
2016	—	46	2,320
2015	—	57	2,497

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,876Scopus Q2SCImago Profile

Scopus Coverage:2009-2026

•

Scopus Broad Areas:MedicinePharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.89

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.35

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,208 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations3,935

3-Year Documents1,131

Citable Documents1,072

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate51.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Internal MedicineQ2

PharmacologyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 3.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区ENDOCRINOLOGY & METABOLISM

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Diabetes Metabolic Syndrome and Obesity-Targets and Therapy (abbr: DIABET METAB SYND OB, ISSN: 1178-7007) is a peer-reviewed international scholarly journal in the field of Pharmacology, published by Dove Medical Press Ltd. in New Zealand. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.890 (Q2), an H-index of 80.

The journal enforces rigorous peer evaluation with an annual output of approximately 439 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,208 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.